Market Movers (8-K)
See all →NASDAQ
Central Garden & Pet Company announced its third quarter fiscal year 2026 financial results, reporting a net sales decrease of 8% but raising its full-year non-GAAP diluted EPS outlook and detailing a significant acquisition in Europe.
Capital raise
NASDAQ
Central Garden & Pet Company announced its definitive agreement to acquire approximately 80% of TRIXIE Heimtierbedarf GmbH & Co. KG, a leading European pet supplies company, for up to €400 million.
NASDAQ
Central Garden & Pet reported a decline in Q1 fiscal 2026 net sales and GAAP EPS, but maintained non-GAAP EPS and expanded gross margins.
NASDAQ
Central Garden & Pet Company announced record fiscal year 2025 profits driven by margin expansion and cost efficiencies, despite a slight dip in net sales.
Better than expected
NASDAQ
Central Garden & Pet Company has entered into a new $600 million senior secured asset-based revolving credit facility, extending its maturity to November 2030.
Capital raise
NASDAQ
Central Garden & Pet Company reported strong third-quarter fiscal 2025 earnings per share growth of 28% to $1.52, driven by margin expansion from productivity efforts, despite a 4% decline in net sales, and reaffirmed its full-year non-GAAP EPS guidance of approximately $2.60.
Quarterly Earnings (10-Q)
See all →NASDAQ
Central Garden & Pet Company reported a decrease in net sales due to the divestiture of its pet distribution business, but saw organic sales growth and improved margins, while announcing a major acquisition in Europe.
Capital raise
NASDAQ
Central Garden & Pet Company announced a 9% increase in net sales for its second fiscal quarter, driven by strong performance in both its Pet and Garden segments, alongside a strategic partnership divesting its pet distribution business.
NASDAQ
Central Garden & Pet Company reported a 6% decline in net sales and a significant drop in net income for Q1 fiscal 2026, driven by shipment timing and portfolio optimization, despite improved gross margins.
Capital raise
Worse than expected
NASDAQ
Central Garden & Pet Company reported increased net income and gross margin for the third quarter and first nine months of fiscal 2025, driven by productivity gains and cost reductions, despite a decline in net sales.
Better than expected
Capital raise
NASDAQ
Central Garden & Pet's Q2 2025 net sales decreased by 7.4%, but gross margins improved by 180 basis points.
Worse than expected
NASDAQ
Central Garden & Pet Company reports a 3.5% increase in net sales and significant improvement in profitability for the first quarter of fiscal year 2025.
Better than expected
Annual Reports (10-K)
NASDAQ
Central Garden & Pet Company reported a significant increase in operating income and net income for fiscal year 2025, driven by improved gross margins and cost efficiencies, despite a slight dip in net sales.
Capital raise
Better than expected
NASDAQ
10-K: Central Garden & Pet Co. Files 10-K, Reports on Financial Performance and Strategic Initiatives
Central Garden & Pet Company's annual 10-K filing details a decrease in net sales, strategic cost-cutting measures, and leadership changes, while highlighting ongoing investments in brand growth and digital capabilities.
Worse than expected
Insider Trading (Form 4)
See all →NASDAQ
Brooks Pennington Iii, a Director of Central Garden & Pet Co, reported a transaction in 5,800 shares of common stock on August 12, 2026.
NASDAQ
William E Brown, Chairman, a Director and 10% owner of Central Garden & Pet Co, sold 3,900 shares of common stock on August 13, 2026 for $39.00 per share.
NASDAQ
William E Brown, Chairman, a Director and 10% owner of Central Garden & Pet Co, reported multiple transactions in common stock on August 10, 2026.
NASDAQ
John D. Walker Iii, President, Garden Consumer Pro of Central Garden & Pet Co, sold 10,000 shares of common stock on August 11, 2026.
NASDAQ
Howard Machek, Chief Accounting Officer of Central Garden & Pet Co, reported a transaction in 3,924 shares of common stock on July 13, 2026.
NASDAQ
John Edward Hanson, President of Pet Consumer Products at Central Garden & Pet Co., reported transactions involving Class A Common Stock and stock options.
Proxy Statements (Def-14A)
See all →NASDAQ
Central Garden & Pet Company filed its definitive proxy statement for the 2026 Annual Meeting, outlining director elections, auditor ratification, and an advisory vote on executive compensation, alongside fiscal 2025 financial performance and compensation details.
NASDAQ
Central Garden & Pet Company has filed definitive additional proxy materials with the SEC.
NASDAQ
Central Garden & Pet Company announces its 2026 Annual Meeting of Shareholders to vote on director elections, auditor ratification, and executive compensation, following a fiscal year with mixed financial results.
NASDAQ
DEFA14A: Central Garden & Pet Company Withdraws Officer Exculpation Proposal Ahead of Annual Meeting
Central Garden & Pet Company has withdrawn a proposal to include an officer exculpation provision from its upcoming Annual Meeting of Stockholders.
NASDAQ
Central Garden & Pet Company has filed a definitive proxy statement with the SEC.
NASDAQ
Central Garden & Pet Company will hold its annual shareholder meeting virtually on February 12, 2025, to vote on director elections, auditor ratification, and an amendment to include officer exculpation.
Worse than expected
Schedule 13G - Passive Investments
See all →NASDAQ
American Century Investment Management, Inc. has increased its beneficial ownership of Central Garden & Pet Company's Class A Common Stock to 5.1%, crossing the 5% threshold and triggering a Schedule 13G filing.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 6.39% of Central Garden & Pet's common stock as of March 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 3,502,876 shares, representing 6.87% of the outstanding common stock of Central Garden & Pet Co.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership of 5.66% in Central Garden & Pet Co. common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Central Garden & Pet Co following an internal realignment.
NASDAQ
The Vanguard Group reports zero beneficial ownership in Central Garden & Pet Co following an internal realignment, disaggregating its reporting.